These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18192843)
61. Sympathetic drive is modulated by central chemoreceptor activation. Pitsikoulis C; Bartels MN; Gates G; Rebmann RA; Layton AM; De Meersman RE Respir Physiol Neurobiol; 2008 Dec; 164(3):373-9. PubMed ID: 18840550 [TBL] [Abstract][Full Text] [Related]
62. Menstrual cycle and sex effects on sympathetic responses to acute chemoreflex stress. Usselman CW; Gimon TI; Nielson CA; Luchyshyn TA; Coverdale NS; Van Uum SH; Shoemaker JK Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H664-71. PubMed ID: 25527774 [TBL] [Abstract][Full Text] [Related]
63. Changes in peripheral chemoreflex sensitivity during sustained, isocapnic hypoxia. Bascom DA; Clement ID; Cunningham DA; Painter R; Robbins PA Respir Physiol; 1990 Nov; 82(2):161-76. PubMed ID: 2127465 [TBL] [Abstract][Full Text] [Related]
64. Effect of verapamil on ventilatory and circulatory responses to hypoxia and hypercapnia in normal subjects. Ohdaira T; Kobayashi T; Tanaka M; Chowdhury MF; Ahn B; Masuda A; Sakakibara Y; Honda Y Jpn J Physiol; 1992; 42(5):765-77. PubMed ID: 1491501 [TBL] [Abstract][Full Text] [Related]
65. Baroreceptor unloading in postural tachycardia syndrome augments peripheral chemoreceptor sensitivity and decreases central chemoreceptor sensitivity. Taneja I; Medow MS; Clarke DA; Ocon AJ; Stewart JM Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H173-9. PubMed ID: 21536847 [TBL] [Abstract][Full Text] [Related]
66. Human obesity is characterized by a selective potentiation of central chemoreflex sensitivity. Narkiewicz K; Kato M; Pesek CA; Somers VK Hypertension; 1999 May; 33(5):1153-8. PubMed ID: 10334803 [TBL] [Abstract][Full Text] [Related]
67. Long-term intermittent hypoxia increases sympathetic activity and chemosensitivity during acute hypoxia in humans. Lusina SJ; Kennedy PM; Inglis JT; McKenzie DC; Ayas NT; Sheel AW J Physiol; 2006 Sep; 575(Pt 3):961-70. PubMed ID: 16809359 [TBL] [Abstract][Full Text] [Related]
68. Peripheral chemoreflex inhibition with low-dose dopamine: new insight into mechanisms of extreme apnea. Bain AR; Dujic Z; Hoiland RL; Barak OF; Madden D; Drvis I; Stembridge M; MacLeod DB; MacLeod DM; Ainslie PN Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1162-71. PubMed ID: 26290106 [TBL] [Abstract][Full Text] [Related]
69. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Narkiewicz K; Pesek CA; van de Borne PJ; Kato M; Somers VK Circulation; 1999 Jul; 100(3):262-7. PubMed ID: 10411850 [TBL] [Abstract][Full Text] [Related]
70. Ventilatory responses to chemoreflex stimulation are not enhanced by angiotensin II in healthy humans. Solaiman AZ; Feehan RP; Chabitnoy AM; Leuenberger UA; Monahan KD Auton Neurosci; 2014 Jul; 183():72-9. PubMed ID: 24556416 [TBL] [Abstract][Full Text] [Related]
71. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Narkiewicz K; van de Borne PJ; Montano N; Dyken ME; Phillips BG; Somers VK Circulation; 1998 Mar; 97(10):943-5. PubMed ID: 9529260 [TBL] [Abstract][Full Text] [Related]
72. Effects of two protocols of intermittent hypoxia on human ventilatory, cardiovascular and cerebral responses to hypoxia. Foster GE; McKenzie DC; Milsom WK; Sheel AW J Physiol; 2005 Sep; 567(Pt 2):689-99. PubMed ID: 15975977 [TBL] [Abstract][Full Text] [Related]
73. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Zevin S; Jacob P; Benowitz NL Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723 [TBL] [Abstract][Full Text] [Related]
74. Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart failure. Velez-Roa S; van de Borne P; Somers VK J Card Fail; 2003 Oct; 9(5):380-3. PubMed ID: 14583899 [TBL] [Abstract][Full Text] [Related]